Cargando…
Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer’s disease mouse model
The orexigenic hormone ghrelin, a potential antagonist of the insulin system, ensures sufficient serum glucose in times of fasting. In the race for new therapeutics for diabetes, one focus of study has been antagonizing the ghrelin system in order to improve glucose tolerance. We provide evidence fo...
Autores principales: | Kunath, Nicolas, van Groen, Thomas, Allison, David B., Kumar, Ashish, Dozier-Sharpe, Monique, Kadish, Inga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473679/ https://www.ncbi.nlm.nih.gov/pubmed/26090621 http://dx.doi.org/10.1038/srep11452 |
Ejemplares similares
-
Hunger in the Absence of Caloric Restriction Improves Cognition and Attenuates Alzheimer's Disease Pathology in a Mouse Model
por: Dhurandhar, Emily J., et al.
Publicado: (2013) -
The effect of a pharmaceutical ghrelin agonist on lifespan in C57BL/6J male mice: A controlled experiment
por: Kaiser, Kathryn A., et al.
Publicado: (2023) -
Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren
por: Liu, Heng, et al.
Publicado: (2021) -
Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
por: Northrup, R., et al.
Publicado: (2013) -
Differential Effects of a Full and Biased Ghrelin Receptor Agonist in a Mouse Kindling Model
por: Buckinx, An, et al.
Publicado: (2019)